These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6590537)

  • 1. Induction of DNA polymerase alpha and terminal deoxynucleotidyl transferase in the human lymphoblastoid cell line Molt-4 by the immunomodulator bestatin.
    Leyhausen G; Dippold W; Zahn RK; Meyer zum Büschenfelde KH; Umezawa H; Müller WE
    Immunopharmacology; 1984 Jun; 7(3-4):151-7. PubMed ID: 6590537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ubenimex (Bestatin) on the cell growth and phenotype of HL-60 and HL-60R cell lines: up-and down-regulation of CD13/aminopeptidase N.
    Imamura N; Kimura A
    Leuk Lymphoma; 2000 May; 37(5-6):663-7. PubMed ID: 11042531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bestatin, an inhibitor of aminopeptidase B, suppresses the proliferation and differentiation of human B-cells in vitro.
    Morikawa K; Morikawa S; Nakano A; Oseko F
    Int J Immunopharmacol; 1989; 11(8):905-13. PubMed ID: 2613395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of death ligand-induced apoptosis by aminopeptidase inhibitors in human solid tumor cell lines.
    Sekine K; Fujii H; Abe F; Nishikawa K
    Int J Cancer; 2001 Nov; 94(4):485-91. PubMed ID: 11745433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties and specificity of binding sites for the immunomodulator bestatin on the surface of mammalian cells.
    Müller WE; Schuster DK; Zahn RK; Maidhof A; Leyhausen G; Falke D; Koren R; Umezawa H
    Int J Immunopharmacol; 1982; 4(5):393-400. PubMed ID: 6982243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of apoptosis by bestatin (ubenimex) in human leukemic cell lines.
    Sekine K; Fujii H; Abe F
    Leukemia; 1999 May; 13(5):729-34. PubMed ID: 10374877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disappearance of terminal deoxynucleotidyltransferase in human malignant T-lymphoblasts treated with a human alpha interferon preparation.
    Takano S; Nakamura H; Mita H; Nagano Y
    Microbiol Immunol; 1984; 28(10):1111-5. PubMed ID: 6335218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic relationships in calf thymus and human leukemic cell terminal deoxynucleotidyl transferase.
    Chan JY; Srivastava BI
    Biochim Biophys Acta; 1976 Oct; 447(3):353-9. PubMed ID: 1067872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Bestatin, a new immunomodulator, on various functions of human monocytes.
    Jarstrand C; Blomgren H
    J Clin Lab Immunol; 1982 Dec; 9(3):193-8. PubMed ID: 7166751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemical identification of the cell surface bound leucine aminopeptidase, the target enzyme for the immunostimulant bestatin.
    Leyhausen G; Gramzow M; Zahn RK; Steffen R; Umezawa H; Müller WE
    J Antibiot (Tokyo); 1983 Jun; 36(6):728-34. PubMed ID: 6348011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogenic potentials of bestatin, amastatin, arphamenines A and B, FK-156 and FK-565 on spleen lymphocytes.
    Weissmann N; Leyhausen G; Maidhof A; Tanaka W; Umezawa H; Müller WE
    J Antibiot (Tokyo); 1985 Jun; 38(6):772-8. PubMed ID: 4019321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of small molecular microbial products modulating immune responses and bestatin.
    Umezawa H
    Recent Results Cancer Res; 1980; 75():115-25. PubMed ID: 7232823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deoxynucleotide-polymerizing enzyme activities in T- and B-cells of acute lymphoblastic leukemia origin.
    Srivastava BI
    Cancer Res; 1976 May; 36(5):1825-30. PubMed ID: 1083765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 12-0-Tetradecanoylphorbol 13-acetate (TPA)-induced enzymatic change of human non-T, non-B lymphoid leukemia cell lines.
    Sasaki R; Kubonishi I; Minowada J; Bollum FJ; Miura Y; Takaku F
    Haematologia (Budap); 1993; 25(2):111-21. PubMed ID: 8244198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic AMP induces terminal deoxynucleotidyl transferase in immature B cell leukemia lines.
    Siden EJ; Gifford A; Baltimore D
    J Immunol; 1985 Aug; 135(2):1518-22. PubMed ID: 2989368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of bestatin on the growth of human leukemic cells.
    Sakurada K; Imamura M; Kobayashi M; Tachibana N; Abe K; Tanaka M; Okabe M; Morioka M; Kasai M; Sugiura T
    Acta Oncol; 1990; 29(6):799-802. PubMed ID: 2223152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of tumor cell invasion by ubenimex (bestatin) in vitro.
    Saiki I; Murata J; Watanabe K; Fujii H; Abe F; Azuma I
    Jpn J Cancer Res; 1989 Sep; 80(9):873-8. PubMed ID: 2513304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of p38 MAPK Phosphorylation Is Critical for Bestatin to Enhance ATRA-Induced Cell Differentiation in Acute Promyelocytic Leukemia NB4 Cells.
    Qian X; He J; Zhao Y; Lin M
    Am J Ther; 2016; 23(3):e680-9. PubMed ID: 24141198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased sensitivity of IL2-dependent cultured T cells and enhancement of in vitro IL2 production by human lymphocytes treated with Bestatin.
    Noma T; Klein B; Cupissol D; Yata J; Serrou B
    Int J Immunopharmacol; 1984; 6(2):87-92. PubMed ID: 6429060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.